Use of Celecoxib in Patients With Intraductal Papillary Mucinous Neoplasms (IPMNs)

计划入组 8 人 · 首次发布于 2005 年 9 月 20 日

Surveillance Discontinuation in 5 Year Stable Trivial Branch Duct Intraductal Papillary Mucinous Neoplasms

计划入组 394 人 · 首次发布于 2025 年 7 月 9 日

Using Radiogenomics to Predict Malignant Potential of Intraductal Papillary Mucinous Neoplasms of the Pancreas

计划入组 1,174 人 · 首次发布于 2020 年 2 月 19 日

second-generation anti-CALR CAR T-cell therapy (myeloproliferative neoplasms)

Luspatercept(Reblozyl)

Rx

Anagrelide(Xagrid, Agrylin, Anagrelide Viatris (previously Anagrelide Mylan))

C₁₀H₇Cl₂N₃O · Rx

Capillary Biomedical, Inc.

United States

NEOPLAS INNOVATION

United States

Immunovia's Next-Generation Pancreatic Cancer Test Shows 77% Detection Rate in Early-Stage Disease

Study Evaluates Impact of Adjuvant Chemotherapy on IPMN-Derived Pancreatic Ductal Adenocarcinoma

Outcomes Remain Poor for Myeloproliferative Neoplasm Blast Phase Despite New Therapies